Puma Biotechnology Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Good afternoon, everyone. My name is Gena Wang. I'm midcap biotech analysts at the Barclays.
Welcome to our Second Virtual Global Healthcare Conference. First, I wish everyone staying healthy, and I would like to thank all the participants, investors, companies and especially our event team and corporate access team, who made this virtual health care conference possible.
With that, I would like to introduce our next presenter, Alan Auerbach, Chief Executive Officer from Puma Biotech. Alan, I hand over to you.
Great. Thank you. So first of all, I would just like to welcome everyone to the Puma Biotechnology presentation. As a reminder, I'll be making forward-looking statements.
So on this slide, you can see our product pipeline for the company. We have one drug that we have brought into the company, which is neratinib, and we have it on the market in 2 indications and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
